AI assistant
Sending…
VERTEX PHARMACEUTICALS INC / MA — Director's Dealing 2012
Jul 26, 2012
29864_dirs_2012-07-26_04783f58-daa1-4745-bc95-a06499bd30ac.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: VERTEX PHARMACEUTICALS INC / MA (VRTX)
CIK: 0000875320
Period of Report: 2012-07-25
Reporting Person: MUELLER PETER (EVP, Global R&D, CSO)
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2012-07-25 | Employee Stock Option (right to buy) | $48.74 | A | 36250 | Acquired | 2022-07-24 | Common Stock (36250) | Direct |
Footnotes
F1: The option vests in 16 quarterly installments beginning on 10/25/2012.
More from VERTEX PHARMACEUTICALS INC / MA
Major Shareholding Notification
2026
May 14
Regulatory Filings
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Share Issue/Capital Change
2026
May 13
Declaration of Voting Results & Voting Rights Announcements
2026
May 13